Quantisnow Logo
Dashboard

Morgan Stanley reiterated coverage on PetMed Express with a new price target

$PETS
Retail-Drug Stores and Proprietary Stores
Consumer Staples
Get the next $PETS alert in real time by email

Weekly insight reads limit reached.

Join Quantisnow to enjoy unlimited reads, alerts, live feeds, and more.

Meet Quantisnow

Stock alerts. Live news feeds. Press releases. Insider trading. FDA approvals & more.

Get startedLearn more

Invest smarter

A better trading workflow

Access market-moving news before they break out to the general public. Let Quantisnow cut out the noise and only receive insights that matter.

Live feeds
Real-time news feeds for Press Releases, SEC Filings, FDA approvals, market insights and more.
Custom filters
Filter out the noise with company filters, market cap filters, price filters and more.
Audio Squawk
Multitask with confidence and let Quantsinow read breaking news out loud.
Product screenshot
Quantisnow AI Features

Save time

Unlock Insights with AI

Get quick summaries and precise Q&A for every insight, empowering you to make informed decisions without sifting through entire press releases and lengthy SEC filings.

Get alerted immediately

All your stock market alerts in one place

Quantisnow alerts are fast, customizable, and versatile.

Email alerts
Subscribe to your favorite stocks and receive email alerts each time a news pops up.
App notifications
Reduce alerting latency with in-app notifications. Same as email alerts, but faster.
Webhooks
Integrate with Quantisnow programmatically and receive live insights via webhooks
Granular alerts
Want to receive Press Releases but no SEC filings? No problem - Quantisnow alerts are highly customizable and can seemlessly tailor to your trading needs.

Elevate your trading.
Start using Quantisnow today.

Never miss an update.

Get startedLearn more
App screenshot

Simple no-tricks pricing

One membership with full access and no delays.

Quantisnow Plus

Your personal trading assistant for just $39/month.

What's included

  • Live feeds
  • Audio squawk
  • Compact mode in feeds
  • Email alerts
  • App push alerts
  • Unlimited insights reads
  • Unlimited subscriptions
  • Advanced filters in live feeds
  • Support
  • No ads
  • AI-generated summaries and Q&A

One membership - all access

$39/month

Get access

$39/month with yearly billing, $49/month with monthly billing

News insights ingested and delivered in real time
5 million+
Real-time news alerts sent out to Quantisnow users
700,000+
Latency of news delivery pipelines to users via mobile app, webhooks, and email
<100ms
Get the next $PETS alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$PETS

DatePrice TargetRatingAnalyst
5/25/2023$20.00Buy
Lake Street
1/25/2022$25.00 → $21.00Underweight
Morgan Stanley
1/20/2022$32.00Neutral → Buy
Sidoti
11/18/2021$25.00Underweight
Morgan Stanley
10/1/2021$28.00Hold
Jefferies
8/5/2021$22.00Underperform
Credit Suisse
More analyst ratings

$PETS
 Press Releases

Fastest customizable press release news feed in the world

See more

  • PetMeds® Announces Third Quarter Fiscal 2025 Financial Results

    DELRAY BEACH, Fla., Feb. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its third quarter ended December 31, 2024. Third Quarter Fiscal 2025 Financial Highlights Net sales of $53.0 million. Gross margin rate of 28.1%, an increase of 80 basis points compared to the prior year period. Adjusted EBITDA of $2.0 million compared to Adjusted EBITDA of $0.9 million in the prior year period. Continued progress on key initiatives supporting the transformation of the business. "In just nine months, we have made significant strides in our transformation journey, and I am pleased to report that

    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

  • PetMed Express, Inc. Sets Fiscal Third Quarter 2025 Earnings Call

    DELRAY BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Monday, February 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fiscal third quarter ended December 31, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Monday, February 10, 2025Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562Webcast

    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

  • PetMed Express, Inc. to Participate in the 27th Annual ICR Conference

    DELRAY BEACH, Fla., Jan. 07, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS), will participate in the 27th Annual ICR Conference, to be held January 13-15, 2025 in Orlando, FL. Sandra Campos, Chief Executive Officer and President, and Robyn D'Elia, Chief Financial Officer, will meet with investors and present at approximately 11:00 a.m. Eastern Time on Monday, January 13, 2025. A live webcast of the presentation will be available on the "Events & Presentations" section of PetMed's investor relations website at https://investors.petmeds.com. About PetMed Express, Inc. Founded in 1996, PetMeds is a leader in the consumer pet health

    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

$PETS
 Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$PETS
 Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$PETS
 Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$PETS
 SEC Filings

See more

$PETS
 Leadership Updates

Live Leadership Updates

See more

  • PetMed Express, Inc. Announces Appointment of Robyn D'Elia as Chief Financial Officer

    DELRAY BEACH, Fla., Sept. 12, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of retail and ecommerce veteran Robyn D'Elia as Chief Financial Officer ("CFO") effective September 16, 2024. D'Elia brings over 25 years of experience in financial leadership and strategic planning across multiple industries, including 24 years at Bed Bath & Beyond where she served in senior leadership roles across finance for two decades, and served as CFO from 2018 to 2020. Most recently D'Elia served as CFO at Odeko, a privately held all-in-one operations partner for independent coffee shops, cafes and ot

    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

  • PetMed Express, Inc. Announces Appointment of Doug Krulik as Chief Accounting Officer

    DELRAY BEACH, Fla., Aug. 05, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced the appointment of Doug Krulik as Chief Accounting Officer (CAO) effective August 19, 2024. Krulik comes to PetMeds with more than 20 years of leadership experience in finance and accounting, most recently with Etherio Holdings as its Vice President Finance and Controller. In this newly created role, he will oversee all aspects of the Company's accounting functions, including financial reporting, treasury, tax, compliance, and internal controls. Krulik will report directly to the Office of the Chief Financial Officer. "Doug'

    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

  • PetMed Express, Inc. Announces Strategic Updates to Executive Leadership Team

    Caroline Conegliano appointed Chief Operating Officer Umesh Sripad appointed Chief Digital and Technology Officer Company Announces CFO transition DELRAY BEACH, Fla., June 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) (the "Company") today announced several changes to its executive leadership team to further advance key initiatives to improve the customer experience, and to accelerate growth and profitability. Chief Operating Officer Caroline Conegliano joins PetMeds as Chief Operating Officer (COO), in a newly created role and expansion of the executive leadership team. Ms. Conegliano brings nearly two decades of experi

    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

$PETS
 Financials

Live finance-specific insights

See more

  • PetMeds® Announces Third Quarter Fiscal 2025 Financial Results

    DELRAY BEACH, Fla., Feb. 10, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) today announced its financial results for its third quarter ended December 31, 2024. Third Quarter Fiscal 2025 Financial Highlights Net sales of $53.0 million. Gross margin rate of 28.1%, an increase of 80 basis points compared to the prior year period. Adjusted EBITDA of $2.0 million compared to Adjusted EBITDA of $0.9 million in the prior year period. Continued progress on key initiatives supporting the transformation of the business. "In just nine months, we have made significant strides in our transformation journey, and I am pleased to report that

    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

  • PetMed Express, Inc. Sets Fiscal Third Quarter 2025 Earnings Call

    DELRAY BEACH, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (NASDAQ:PETS) will hold a conference call on Monday, February 10, 2025 at 4:30pm Eastern Time to discuss its financial results for the fiscal third quarter ended December 31, 2024. Financial results will be issued in a press release prior to the call. PETS management will host the conference call, followed by a question-and-answer period. Please call the conference telephone number 5-10 minutes prior to the start time. Date: Monday, February 10, 2025Time: 4:30pm Eastern Time (1:30pm Pacific Time)U.S. dial-in number: 877-407-0789International number: 201-689-8562Webcast

    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

  • PetMeds® Adopts Limited Duration Shareholder Rights Plan

    DELRAY BEACH, Fla., Dec. 03, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx (NASDAQ:PETS) ("PetMeds" or the "Company"), today announced that its Board of Directors (the "Board") has adopted a limited duration shareholder rights plan to protect the best interests of all PetMeds shareholders (the "Rights Plan"). The Board adopted the Rights Plan to protect the investment of shareholders during a period in which it believes shares of the Company do not reflect the inherent value of the business or its long-term growth potential, and during which there have been recent significant accumulations of Company common stock by certain shareholders.

    $PETS
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

$PETS
 Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more